Court throws out $223.8 million verdict against Johnson & Johnson in relation to talc cancer claims
A significant development in the ongoing story around claims about asbestos in Johnson & Johnson’s talc powder products occurred on Tuesday 3rd October, when an appeals court in New Jersey tossed an earlier $223.8 million (£184.7 million) verdict against the company.